AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnston, J. L.
Right arrow Articles by Anderson, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnston, J. L.
Right arrow Articles by Anderson, G. H.
Agricola
Right arrow Articles by Johnston, J. L.
Right arrow Articles by Anderson, G. H.

American Journal of Clinical Nutrition, Vol 38, 356-368, Copyright © 1983 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Obesity and precursor availability affect urinary catecholamine metabolite production in women

JL Johnston, JJ Warsh and GH Anderson

The effect of obesity and tyrosine (tyr) supplements on catecholamine metabolism in 12 normal weight and nine obese adult women was studied. Protein intake was maintained at 1.4 g protein/kg fat-free mass daily for 4 days with tyr added (0.26 g/kg fat-free mass) to the liquid diet on the last 2 days. In the 12 normal subjects, but not the obese, base- line urinary excretion of the norepinephrine metabolite, 3-methoxy-4- hydroxy phenylethyleneglycol was related to body fat whereas excretion of the norepinephrine metabolite vanilmandelic acid was related to fat- free mass and to total energy intake. Normal subjects responded to tyr with elevations in plasma tyr/neutral amino acid, plasma 3-methoxy-4- hydroxy phenylethyleneglycol, urinary vanilmandelic acid, and homovanillic acid, a dopamine metabolite, but not the norepinephrine metabolite, dihydroxy phenylethyleneglycol. The obese showed no increase in plasma or urinary 3-methoxy-4-hydroxy phenylethyleneglycol during tyr supplementation, although vanilmandelic acid and homovanillic acid increased. We conclude that urinary catecholamine metabolite production is related to body composition and to tyr intake in normal weight women. These relationships however, are altered in the obese, suggesting an association of obesity with abnormal catecholamine metabolism.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by The American Society for Nutrition